Innovations in Hepatitis C Screening and Treatment

Arpan Patel(West Los Angeles College), Ponni Perumalswami(Icahn School of Medicine at Mount Sinai), Aileen Bui(University of California, Los Angeles), Andrea D. Branch(Icahn School of Medicine at Mount Sinai), Eian G. Prohl(University of California, Los Angeles), Debika Bhattacharya, Su Wang(Rutgers, The State University of New Jersey)
Hepatology Communications
November 10, 2020
10.1002/hep4.1646
Cited by 42

Related Papers

Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
Zika Virus NS4A and NS4B Proteins Deregulate Akt-mTOR Signaling in Human Fetal Neural Stem Cells to Inhibit Neurogenesis and Induce Autophagy
|Cell stem cell|2016|565
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
|Journal of Hepatology|2020|525
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡
|Journal of Hepatology|2019|364
Neonatal Chimerization with Human Glial Progenitor Cells Can Both Remyelinate and Rescue the Otherwise Lethally Hypomyelinated Shiverer Mouse
|Cell stem cell|2008|329